A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.
Tan, J., Sack, B.K., Oyen, D., Zenklusen, I., Piccoli, L., Barbieri, S., Foglierini, M., Fregni, C.S., Marcandalli, J., Jongo, S., Abdulla, S., Perez, L., Corradin, G., Varani, L., Sallusto, F., Sim, B.K.L., Hoffman, S.L., Kappe, S.H.I., Daubenberger, C., Wilson, I.A., Lanzavecchia, A.(2018) Nat Med 24: 401-407
- PubMed: 29554084 
- DOI: 10.1038/nm.4513
- Primary Citation of Related Structures:  
6BQB - PubMed Abstract: 
Immunization with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria, but the features of the antibody response induced by this treatment remain unclear. To investigate this response in detail, we isolated IgM and IgG monoclonal antibodies from Tanzanian volunteers who were immunized with repeated injection of Sanaria PfSPZ Vaccine and who were found to be protected from controlled human malaria infection with infectious homologous PfSPZs ...